Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. External Web Site Icon Yarmolinsky James et al. JAMA 2020 Feb (7) 646-655

Hot Topics of the Day|PHGKB

What's New

Last Posted: Feb 20, 2020

---

• Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. 
  Yarmolinsky James et al. JAMA 2020 Feb (7) 646-655
• Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors. 
  Reid Sonya et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Feb
• The pan-cancer landscape of prognostic germline variants in 10,582 patients. 
  Chatrath Ajay et al. Genome medicine 2020 Feb (1) 15
• Management of Male Breast Cancer: ASCO Guideline. 
  Hassett Michael J et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Feb JCO1903120
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer. 
  Mills Justin et al. American family physician 2020 Feb 101(4) 239-240
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement. 
  et al. American family physician 2020 Feb 101(4) 233-238
• [Clinical Cancer Genetics: A guide for the pathologist]. 
  Basset Noémie et al. Annales de pathologie 2020 Feb
• [Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications]. 
  Koual Meriem et al. Annales de pathologie 2020 Feb
• A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results. 
  Cortesi Laura et al. Cancer medicine 2020 Feb
• Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice. 
  Xing Lu et al. DNA and cell biology 2020 Feb
• Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study. 
  Yoon Hee-Young et al. PloS one 2020 15(2) e0228925
• Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages. 
  Guibert Nicolas et al. European respiratory review : an official journal of the European Respiratory Society 2020 Mar 29(155)
• Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. 
  Shen Chengquan et al. International immunopharmacology 2020 Feb 81106274
• Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementation. 
  Radke Teja Falk et al. European journal of human genetics : EJHG 2020 Feb
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? 
  Angeli Davide et al. International journal of molecular sciences 2020 Feb 21(3)